1. Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results. Issue 1 (December 2015) Authors: Amin, Asim; Dudek, Arkadiusz; Logan, Theodore; Lance, Raymond; Holzbeierlein, Jeffrey; Knox, Jennifer; Master, Viraj; Pal, Sumanta; Miller, Wilson; Karsh, Lawrence; Tcherepanova, Irina; DeBenedette, Mark; Williams, W; Plessinger, Douglas; Nicolette, Charles; Figlin, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗